Agoracom Blog

Avicanna $AVCN.ca Closes Non-Brokered Private Placement Raising $2.7 Million $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 4:51 PM on Tuesday, August 18th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Closed a non-brokered private placement
  • Under the Offering, the Company has issued an aggregate of 1,952,410 units at a price of CAD$1.40 per Unit for aggregate gross proceeds of approximately CAD$2.7 million.

TORONTO, Aug. 18, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, is pleased to announce that it has closed a non-brokered private placement (the “Offering“). Under the Offering, the Company has issued an aggregate of 1,952,410 units (the “Units“) at a price of CAD$1.40 per Unit for aggregate gross proceeds of approximately CAD$2.7 million.

Setu Purohit, President of Avicanna commented, “We are very grateful for the continued support from our long-term and strategic investors who continue to demonstrate confidence in our business model and management team, especially in this challenging socio-economic environment. With this financing, we are able to strengthen our balance sheet, which coupled with our efforts to lower costs and see increase revenues gives us the bandwidth to continue to execute our business model.”

Each Unit is comprised of one (1) common share in the capital of the Company (each, a “Common Share“) and one-half of one (1/2) common share purchase warrant (each whole warrant, a “Warrant“). Each Warrant is exercisable into one common share in the capital of the Company (each, a “Warrant Share“) at a price of CAD$2.00 per Warrant Share until August 18, 2022, subject to the Company’s right to accelerate the expiry date of the Warrants on not less than thirty (30) days’ notice in the event that the volume weighted average trading price of the Common Shares exceeds CAD$3.00 for any ten (10) consecutive trading days on the Toronto Stock Exchange.

The Company intends to use the proceeds from the Offering for corporate development and general working capital purposes.

All securities issued under the Offering, including securities issuable on exercise thereof, are subject to a hold period expiring four months and one day from the date hereof. The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Toronto Stock Exchange.

The issuance and sale of 48,970 Units pursuant to the Offering to certain directors and officers of the Company constituted related party transactions within the meaning of Multilateral Instrument 61-101-Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1) (a) of MI 61-101, on the basis that the fair market value of the participation in the Offering by the insiders does not exceed 25% of the market capitalization of the Company, as determined in accordance with MI 61-101. The Company did not file a material change report in respect of the related party transaction at least 21 days before the closing of the Offering, which the Company deems reasonable in the circumstances so as to be able to avail itself of the proceeds of the Offering in an expeditious manner.

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the use of proceeds of the Offering. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

VIDEO – $KABN.ca Announces ~$3,000,000 Financing At 100% Premium With US Family Office and Foreign Investors $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 4:26 PM on Tuesday, August 18th, 2020
kabn-square-new

The headline pretty much speaks for itself this morning and it looks like the smallcap world is about to wake up to the FinTech potential of KABN.

What does KABN do that warrants such a significant financing at 100% premium to its’ closing price yesterday?

KABN Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models. 

Rather than trying to get you to understand what that exactly means by reading it here, be prepared to be blown away by KABN in this interview with Company President David Lucatch.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

American Creek $AMK.ca Announces Significant Expansion of the D1-McBride Property in BC’s Golden Triangle $TUD.ca $SII.ca $GTT.ca $AFF.ca $SEA.ca $SA $PVG.ca $AOT.ca $ESK.ca

Posted by AGORACOM at 3:39 PM on Tuesday, August 18th, 2020
  • The D1-McBride property is located 60 km northeast of the Red Chris mine (Imperial Metals / Newcrest Mining)

Cardston, Alberta–(Newsfile Corp. – August 18, 2020) – American Creek Resources Ltd. (TSXV: AMK) (“the Corporation”) is pleased to report that it has significantly expanded its D1-McBride property located in the northeast corner of British Columbia’s Golden Triangle. The new claim block encompasses an area of approximately 2,600 hectares immediately adjacent to and surrounding the Corporation’s original 34-hectare D1-McBride property. The Corporation holds a 100% interest in the property.

The D1-McBride property is located in the Liard Mining Division, about 64 km southeast of Dease Lake and 60 km northeast of the Red Chris mine (Imperial Metals / Newcrest Mining). This area of the Stikine Mountain Range has a history of placer gold and Jade mines. It is quickly becoming a hotbed of activity as companies are starting to recognize the potential it holds.

According to BC MINFILE No 104-093, the property is host to a galena and gold bearing quartz/calcite vein system. According to Assessment Report 35096, work on the property in 2014 included limited rock sampling of a vein subcrop from the Discovery Showing which returned high grade assays of 43.1 g/t gold, 240 g/t silver, 1.8% lead and 1.98% zinc and 13.1 g/t gold, 16 g/t silver, 2.32% lead and 3.02 zinc. Previous sampling of veins returned assays of 161.32 g/t gold, 1,110.9 g/t silver, 3.17% lead and 2.1% zinc across 10 centimeters and 115.89 g/t gold, 589.72 g/t silver, 12.3% lead and 11.04 oz/t zinc across 25 centimeters (Assessment Report 14004). The vein strikes 030 degrees with a vertical dip and has been traced, through prospecting and trenching, for 30 meters on surface. The overburden-covered lineament in which the vein occurs can be traced for 300 meters (MINFILE N0 104-093).

The additional claims expand the property to cover the projected trace of the exposed veining system, the fault system believed to be related to the mineralization, and regional faults. The property now spans 2,600 hectares, making it the Corporation’s largest single property. Very limited past exploration has taken place on the property.



D1-McBride Claims

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/682/62018_americancreek1enhanced.jpg

This most recent expansion of the D1-McBride is part of the Corporation’s ongoing strategy of adding shareholder value by increasing its gold and silver property portfolio in key exploration and mining camps such as the Golden Triangle. The Golden Triangle is quickly becoming one of the world’s premiere exploration jurisdictions. While there is a strong history of mining in the northeast part of the Triangle, the vast majority of this portion of the Triangle is still relatively untouched and awaiting exploration.

Qualified Person

The Qualified Person for this news release for the purposes of National Instrument 43-101 is Jim McCrea, P.Geo. He has read and approved the scientific and technical information that forms the basis for the disclosure contained in this news release.

About American Creek

American Creek holds a strong portfolio of gold and silver properties in British Columbia.

The portfolio includes three Golden Triangle gold/silver projects; the Treaty Creek joint venture with Walter Storm/Tudor Gold, as well as the 100% owned D-1 McBride property and 100% owned past-producing Dunwell Mine.

Other properties held throughout BC include the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King.

For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com.

PyroGenesis $PYR.ca Signs $3M Contract with $HPQ.ca Subsidiary; Includes IP Sale of $2.4MM $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 1:55 PM on Tuesday, August 18th, 2020
  • Announced today that it has signed a contract for approx. $3MM with HPQ Nano Silicon Powders Inc, a wholly owned subsidiary of HPQ Silicon Resources Inc.
  • This Contract has been developed to exploit the benefits of the novel PUREVAP™ Nano Silicon Reactor (NSiR) to make nano Silicon powder with the battery market as a principle target
  • Specifically, this program has been divided into two phases; i) to modify the existing GEN2 PUREVAP™ QRR in order to produce silicon nano powders and nanowires needed for the next generation of Lithium-ion (Li-ion) Si batteries, and ii) to design and manufacture a semi-continuous process system with a commercial production capacity of at least 300 kg/month (or about 3.5 MT/year) of nano silicon powders

MONTREAL, Aug. 18, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that it has signed a contract for approx. $3MM (the “Contract”)  with HPQ Nano Silicon Powders Inc (“HPQ NANO” or the “Client”), a wholly owned subsidiary of HPQ Silicon Resources Inc (“HPQ”).

This Contract has been developed to exploit the benefits of the novel PUREVAP™ Nano Silicon Reactor (NSiR) to make nano Silicon powder with the battery market as a principle target. Specifically, this program has been divided into two phases; i) to modify the existing GEN2 PUREVAP™ QRR in order to produce silicon nano powders and nanowires needed for the next generation of Lithium-ion (Li-ion) Si batteries, and ii) to design and manufacture a semi-continuous process system with a commercial production capacity of  at least 300 kg/month (or about 3.5 MT/year) of nano silicon powders.  

Research1 indicates that replacing graphite with nano silicon powders could allow the manufacturing of high-performance Li-ion batteries with the capability of delivering an almost tenfold (10x) increase in anode capacity, inducing a 20-40% gain in the energy density of the next generation of Li-Ion batteries. The Li-ion battery market size is estimated to grow from USD 44.2 billion in 2020 to USD 94.4 billion by 2025, equivalent to a CAGR of 16.4%.2  Manufacturing of Si nano powders is not yet commercially feasible with selling prices of US$ 30,000/kg.3  (Please refer to HPQ press release dated August 18th, 2020 for further details).

This Agreement includes $2.4MM for the sale of the intellectual property (IP) rights to the PUREVAP™ NSiR process, together with a 10 % royalty on the Client’s future sales (“Royalty”) (with set minimums). The IP sold relates exclusively to the manufacturing of nano silicon powders and wires by HPQ NANO. PyroGenesis will retain a royalty-free, exclusive, irrevocable, worldwide license to use the System for all other purposes. This Royalty stream can at any time be converted by PyroGenesis into a 50% ownership of the Client.

“This Agreement represents another significant milestone in our relationship with HPQ. Battery storage is the future and it is indeed exciting for us to now be using our plasma expertise in addressing the challenges facing the lithium battery market,” said M. P Peter Pascali, President and CEO of PyroGenesis. “This milestone is also a testament to what can be achieved when two companies, and their Boards, work together with a common purpose and a clear understanding of the many unforeseen challenges in bringing such product lines to fruition.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

________________________ 
1 https://cen.acs.org/materials/energy-storage/battery-materials-world-anodes-time/97/i142 https://www.marketsandmarkets.com/Market-Reports/lithium-ion-battery-market-49714593.html#:~:text=Lithium%2DIon%20Battery%20Market%20size,at%20a%20CAGR%20of%2016.4%25.
3 HPQ Corporate presentation 2020-06-30  https://hpqsilicon.com/wp-content/uploads/2020/06/HPQ-NEW-FULL-SIZE-VER_JUNE_30_2020.pdf

HPQ Silicon $HPQ.ca and Pyrogenesis $PYR.ca Sign a Nano Silicon Development Agreement to Pursue Strong Industry Interest Generated by PUREVAP Nano Silicon Reactor $DUK $XEL $NEE

Posted by AGORACOM-JC at 1:13 PM on Tuesday, August 18th, 2020
  • Signed a development agreement covering the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) development program and the future commercialisation of nano silicon materials made with this new, proprietary and low cost manufacturing process
  • The process will transform Silicon (Si) into spherical Silicon nanopowders and nanowires for use in Li-ion batteries
  • Research indicates that replacing graphite with Nano Silicon (Si) Powders could allow the manufacturing of high-performance Li-ion batteries to deliver an almost tenfold (10x) increase in anode capacity, inducing a 20-40% gain in the energy density of the next generation of Li-Ion batteries

MONTREAL, Aug. 18, 2020 — HPQ Silicon Resources Inc.  (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGEOther OTC : URAGF; is pleased to announce that HPQ Nano Silicon Powders Inc (“HPQ NANO”), a 100% owned HPQ subsidiary, and PyroGenesis Canada Inc. (TSX-V: PYR) have signed a development agreement covering the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) development program and the future commercialisation of nano silicon materials made with this new, proprietary and low cost manufacturing process.  The process will transform Silicon (Si) into spherical Silicon nanopowders and nanowires for use in Li-ion batteries.

INDUSTRY INTEREST GENERATED FROM PREVIOUS ANNOUNCEMENTS NECESSITATE AGREEMENT 

On January 15, 2020 the Companies announced proof of concept testing demonstrating capacity to produce spherical nanopowders & nanowires from silicon (Si) needed by the Lithium-ion battery market.

That announcement was followed by an announcement on February 11, 2020 stating the Companies were developing NSiR for low-cost manufacturing of spherical Silicon (Si) nanopowders & nanowires for next generation Lithium-ion batteries.

As a result of these two announcements, strong and increasing industry interest in our project, even at this early stage of our development, dictates that HPQ and PyroGenesis take this next step.

INTEREST IN PUREVAPTM NSiR GAME CHANGING LOW COST POTENTIAL

Research indicates that replacing graphite with Nano Silicon (Si) Powders could allow the manufacturing of high-performance Li-ion batteries to deliver an almost tenfold (10x) increase in anode capacity, inducing a 20-40% gain in the energy density of the next generation of Li-Ion batteries. Silicon Nanomaterial potential to meet energy storage demand of the future is undeniable and is generating massive investments.

Despite the strong research and investment in Silicon nanomaterial, current manufacturing processes to make Nano Silicon powders are not scalable or commercially viable. HPQ and Pyrogenesis, via this agreement, are developing a process to address both the scalability and cost hurdles required by the industry.  

“The PUREVAPTM NSiR process was conceived and is being developed so that HPQ NANO can deliver to advanced materials companies and battery manufacturers a cost competitive, tailor-made product, that can replace graphite in batteries and thereby allow the deployment of truly powerful next generation Li-ion batteries.  Industry interest in our project is strong, even at this early stage of our development” said Bernard Tourillon, President & CEO of HPQ Silicon.  “This agreement allows us to devote all our efforts in a dedicated entity focussed on starting, as soon as possible, the PUREVAPTM NSiR and shipping samples of our Silicon nanomaterials.  Once the PUREVAPTM NSiR process is operational, expected to be in Q4 of 2020, HPQ NANO will implement the steps required to take full advantage of this unique multibillion-dollar business opportunity”.

“This Agreement represents another significant milestone in our relationship with HPQ. Battery storage is the future and it is indeed exciting for us to now be using our plasma expertise in addressing the challenges facing the lithium battery market,” said M. P Peter Pascali, President and CEO of PyroGenesis Canada Inc. “This milestone is also a testament to what can be achieved when two companies, and their Boards, work together with a common purpose and a clear understanding of the many unforeseen challenges in bringing such product lines to fruition.”

PROCESS VALIDATION AND IMPROVEMENT, NANO Si PRODUCTION & DEMONSTRATING SCALABILITY

The key areas covered by the agreement between HPQ NANO and PyroGenesis are:

  1. PUREVAPTM NSiR process development program, schedule and cost assumed by HPQ NANO;
  2. Acquisition of the PUREVAPTM NSiR Intellectual Property as it relates to the manufacturing of Nano Silicon powders and nanowires by HPQ NANO;
  3. Revenue distribution between HPQ NANO and PyroGenesis from the sales of Nano Silicon materials made with the PUREVAPTM NSiR.

The PUREVAPTM NSiR process development program is made of two distinct and complimentary phases, each with their own goals, timelines and milestones.

PHASE 1, VALIDATING AND IMPROVING THE PROCESS, MAKING SAMPLES BY END OF Q4 2020

The main goal of Phase 1 is modifying the existing Gen2 PUREVAPTM QRR reactor into the Gen1 NSiR for the purpose of producing nano silicon materials.  The resulting new Gen1 NSiR will be a batch process system with a design production capacity of 30 kg/month of nano silicon powders.  In order to meet the aggressive Phase 1 timeline agreed by the Parties, HPQ NANO will pay $200,000 to PyroGenesis over the next 15 weeks needed to complete the process engineering, mechanical engineering, fabrication and system commissioning.

Once the Gen1 NSiR is operational, as series of test runs will be done in order to produce nano Silicon materials.  In addition to producing samples for potential customers, the nano Silicon material produced will be analysed and characterized in order to define important process parameters, fine tune operating parameters and assess the performance of all the components of the systems.  HPQ NANO and PyroGenesis have agreed that each series of 10 tests would cost HPQ NANO $132,000.

PHASE 2, VALIDATING COMMERCIAL SCALABILITY, DELIVERING NANO SI MATERIALS

Phase 2 main objective is validating the commercial scalability of the PUREVAPTM NSiR.  Using data collected during Gen1 NSiR testing phase a completely new Gen2 NSiR system will be designed and built.  35 weeks will be needed to complete the process engineering, mechanical engineering, fabrication and system commissioning and HPQ NANO will pay $210,000 to PyroGenesis for this phase.

The Gen2 NSiR will be a semi-continuous process system with a design production capacity of 300 kg/month (or about 3,5 MT/year) of nano silicon powders or nanowires, giving HPQ NANO a large enough production capacity to be able to start selling nano silicon materials.  In addition to producing nano Silicon material, a series of Gen2 NSiR tests will be done to define the important process parameters and operating parameters required to allow the process and the systems to be scaled up to a commercial production capacity of about 2,500 MT of Nano-Silicon powders per year.

PUREVAPTM NSiR INTELLECTUAL PROPERTY AS IT RELATES TO NANO SILICON MATERIALS

The agreement also covers HPQ NANO acquisition of the intellectual property rights to the PUREVAP™ Nano Silicon (Si) Reactor process as it relates exclusively to the production of Micron size and Nano size Silicon Powders and Silicon Nanowires (the “Field”) from PyroGenesis. The acquisition cost of the PUREVAP™ NSiR IP is CAD$2,400,000 and HPQ NANO has 30 days from the effective date of the agreement to make the payment to PyroGenesis.

PyroGenesis will retain a royalty-free, exclusive, irrevocable worldwide license to use the process for purposes other than the production of Micron size and Nano size Silicon Powders and Silicon Nanowires.  Should PyroGenesis be approached by any other parties for any research and development or commercial purposes outside of the Field, HPQ NANO shall have a right of first refusal, provided that, however, HPQ NANO exercise its right of first refusal within thirty (30) days of PyroGenesis receiving a bona-fide offer.

NSIR REVENUES SPLIT BETWEEN HPQ NANO AND PYROGENESIS FROM SALES OF NANO SI MATERIALS

HPQ and PyroGenesis evaluated the short and long-term advantages of forming, at the start, a stand-alone joint venture responsible for manufacturing and selling Nanoscale Silicon (Si) powders.

A gradual approach was deemed more efficient, therefore HPQ Silicon created a fully own subsidiary, HPQ NANO Silicon Powders Inc, to be the stand-alone Corporation that would finance the Research and Development programs and manage the future commercialisation of Nanoscale Silicon (Si) materials made with the PUREVAPTM NSiR with PyroGenesis being granted the right to convert, at any time and at its sole discretion, it Royalty into a 50% equity stake in HPQ NANO.

As a result of this, HPQ NANO agrees to pay PyroGenesis, on an annual basis, and until conversion, the following minimum royalty (Nano-Royalty) on the gross sales of nano materials produced with the PUREVAPTM NSiR Process and Systems:

  • For 2021, the greater of 10% of HPQ NANO gross sales or fifty thousand dollars (CDN$50,000);
  • For 2022, the greater of 10% of HPQ NANO gross sales or one hundred thousand dollars (CDN$100,000);
  • For 2023, the greater of 10% of HPQ NANO gross sales or one hundred and fifty thousand dollars (CDN$150,000);
  • For 2024 and beyond, the greater of 10% of HPQ NANO gross sales or two hundred thousand dollars (CDN$200,000).

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way.  Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
    • HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • The PUREVAPTM Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    • HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
    • During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
    • The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/2771b596-319e-4159-bfdf-35c6d04ed557

https://www.globenewswire.com/NewsRoom/AttachmentNg/6f635a97-9656-4d6f-8976-cd6468a98cb4
https://www.globenewswire.com/NewsRoom/AttachmentNg/18239f5c-0a59-41d6-a5c5-0f909ddd8687
IMAGE #1 PUREVAP NSiR Phase1 Tentative Timeline
Image 1): Indicative phase 1 project timelines
IMAGE #2 PUREVAP NSiR Phase2 Tentative Timeline
Image 2): Indicative phase 2 project timelines
Image #3 – PUREVAP NSiR Scaling Up
Image 3): Indicative scaling up pathway for PUREVAPTM NSiR

Source: GlobeNewswire (August 18, 2020 – 1:06 PM EDT)

News by QuoteMedia
www.quotemedia.com

VIDEO: Innocan Pharma $INNO.ca teams up with Endless Sky to manufacturer and distribute its #CBD products $WEED.ca $CL.ca $HEXO.ca

Posted by AGORACOM-JC at 12:11 PM on Tuesday, August 18th, 2020
Innocan-Blog
https://youtube.com/watch?v=leIG2iznw8g

Innocan Pharma Corporation (CSE:INNO) CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the two have signed a manufacturing and distribution agreement.

Bincovich says Endless Sky will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its Health Canada-licensed facility in Redvers, Saskatchewan.

In exchange, ESI will pay Innocan Israel a fee per product in addition to royalties based on net sales.

Source: https://ca.proactiveinvestors.com/companies/news/926966/innocan-pharma-teams-up-with-endless-sky-to-manufacturer-and-distribute-its-cbd-products-926966.html

KABN NA $KABN.ca Receives Subscription Agreements for C$2,970,000 Investment at $0.33 CDN per Unit $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 11:31 AM on Tuesday, August 18th, 2020
kabn-square-new
  • Announced that it has received and accepted irrevocable subscriptions from a group of arm’s-length U.S. family office and foreign investors, for a total of 9 million common share units for gross proceeds of C$2,970,000
  • Each Unit is priced at C$0.33 per Unit.
  • Each Unit consists of one common share of the Company and ½ Common Share purchase warrant, with each whole Warrant entitling the holder to purchase one Common Share for C$0.37 per share for 24 months from closing of the transaction
  • “This agreement largely stems from the increasing recognition of Liquid Avatar as a potential game changer in the world of digital identity verification, management and monetization. We look forward to closing this financing over the next couple of weeks and continue to execute and deliver on our business programs,” said Ben Kessler, CEO – KABN North America

Toronto, Canada, August 18, 2020KABN Systems NA Holdings Corp.  (CSE:KABN) (the “Company” or “KABN” or “KABN North America”), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has received and accepted irrevocable subscriptions from a group of arm’s-length U.S. family office and foreign investors, for a total of 9 million common share units (“Units”) for gross proceeds of C$2,970,000. 

Each Unit is priced at C$0.33 per Unit. Each Unit consists of one common share of the Company (“Common Shares”) and ½ Common Share purchase warrant (“Warrants”), with each whole Warrant entitling the holder to purchase one Common Share for C$0.37 per share for 24 months from closing of the transaction.  No fees were paid in association with the financing.  In accordance with applicable securities rules and regulations, the Common Shares and the Warrants comprised in the Units, and the Common Shares issuable on exercise of the Warrants, will be subject to hold periods ranging from 4 months to 1 year, with the majority of the offering subject to a 1 year hold, restricting shares and warrants from transfer or trading except as permitted by law. 

“This agreement largely stems from the increasing recognition of Liquid Avatar as a potential game changer in the world of digital identity verification, management and monetization.  We look forward to closing this financing over the next couple of weeks and continue to execute and deliver on our business programs,” said Ben Kessler, CEO – KABN North America

The expected date of closing is on or before August 31, 2020, and may be extended by the Company.  The proceeds of the financing will provide working capital to further accelerate the Company’s development, customer acquisition and business platform consisting of Liquid Avatar, KABN ID, KABN KASH and KABN’s Visa Card program.

The KABN North American Fintech suite of products and services is comprised of:

Liquid Avatar allows users to create high quality digital icons representing their online personas.  These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want.  www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.  www.kabncard.com


KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

The Company welcomes the public to request an invitation to be an early adopter of Liquid Avatar and earn rewards at: https://liquidavatar.com/liquid-avatar-early-adopter/

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high quality digital icons representing their online personas.  These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want.  www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.  www.kabncard.com


KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler

Chief Executive Officer

647-725-7742 Ext. 700

[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, including to accelerate the Company’s development, customer acquisition and business platform, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation.  Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Durango $DGO.ca Completes $2.82-Million Private Placement $BTR.ca $OSK.ca $SII.ca $TLG.ca

Posted by AGORACOM at 6:06 PM on Monday, August 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/06/DGO-Small-square.png
  • DURANGO COMPLETES $2.8M FINANCING WITH A LEAD ORDER FROM PALISADES GOLDCORP

Ms. Marcy Kiesman reports

Durango Resources Inc. has closed a non-brokered private placement of 13.15 million flow-through units at a price of 12.25 cents per unit and 16.25 million non-flow-through units at a price of 7.5 cents per unit to raise gross proceeds of $2,829,625.

The Company received a lead order from a syndicate of strategic investors led by Palisades Goldcorp Ltd. to purchase 10,000,000 flow-through units. The flow-through units were sold on a charitable flow-through basis.

Each flow-through unit consists of one common share and one half warrant. Each full warrant entitles the holder to purchase an additional common share at a price of $0.15 until August 13, 2023. A total of 13,150,000 flow-through units were issued for gross proceeds of $1,610,875.00. The gross proceeds from the issuance of the flow-through shares will be used in Quebec for “Canadian exploration expenses” within the meaning of the Income Tax Act (Canada). All flow-through securities issued pursuant to the flow through placement (including any shares issued on the exercise of the warrants) are subject to a hold period expiring on December 15, 2020.

Each non flow-through unit consists of one common share and one half warrant. Each full warrant entitles the holder to purchase an additional common share at a price of $0.15 until August 16, 2023. A total of 16,250,000 non flow-through units were issued for gross proceeds of $1,218,750.00.

Durango will use the net proceeds from the non flow-through offering for general working capital and for exploration of its gold properties at Windfall Lake. All securities issued pursuant to the non flow through placement (including any shares issued on the exercise of the warrants) are subject to a hold period expiring on December 18, 2020.

Marcy Kiesman, CEO of Durango, comments: “We are so pleased to have completed this financing with a lead order from Palisades Goldcorp. After months of preparation and planning, our team is eager to commence our exploration program at Windfall Lake in the near future.”

Durango paid aggregate finders’ fees of $153,650.00 and 743,708 full broker warrants exercisable at $0.15 per share until August 13, 2023 in respect of the placements.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company is positioned for discovery with a 100% interest in a strategically located group of properties in the Windfall Lake gold camp in the Abitibi region of Quebec , Canada.

About Palisades Goldcorp

Palisades Goldcorp is Canada’s new resource focused merchant bank. Palisades’ management team has a demonstrated track record of making money and is backed by many of the industry’s most notable financiers. With junior resource equities valued at generational lows, management believes the sector is on the cusp of a major bull market move. Palisades is positioning itself with significant stakes in undervalued companies and assets with the goal of generating superior returns.

Thoughtful Brands $TBI.ca Enters into Letters of Intent to Consider Acquisitions of Golden Path and Wild Mariposa $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 6:02 PM on Monday, August 17th, 2020
Throught-brands-logo-small
  • Entered into letters of intent with Golden Path LLC and Wild Mariposa LLC, pursuant to which it proposes to acquire all of the outstanding membership interests in both companies
  • Golden Path and Wild Mariposa are arms-length privately held companies involved in the online marketing and distribution of consumer health products

VANCOUVER, BC /  August 17, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1:GR)(OTCQB:PEMTF) (the “Company“) is pleased to announce that it has entered into letters of intent (collectively, the “Letters of Intent“), each dated August 17, 2020, with Golden Path LLC (“Golden Path“) and Wild Mariposa LLC (“Wild Mariposa“), pursuant to which it proposes to acquire all of the outstanding membership interests in both companies. Golden Path and Wild Mariposa are arms-length privately held companies involved in the online marketing and distribution of consumer health products.

Golden Path and Wild Mariposa are direct-to-consumer eCommerce brands selling a range of natural health products, including nutraceutical and hemp-based CBD products within the United States. Each product is carefully crafted based on market demand and product quality. Every product manufactured is third-party tested for purity and manufactured in the United States in GMP certified facilities. Both brands are current clients of Unified Funding, LLC which is contracted to perform a number of eCommerce business operations.

We are excited to look at the acquisition of these two established natural health brands as a further step in our eCommerce expansion in North America. Both brands possess product lines that are complimentary to Nature’s Exclusive and bring a large existing customer base along with nutraceutical product formulations and manufacturing relationships. Our timing is very strategic to acquire these brands as we near the closing of the Unified Funding asset acquisition, which will manage all go forward eCommerce operations for Thoughtful Brands”, stated Ryan Hoggan, CEO of the Company.

The Letters of Intent contemplate that the Company would acquire Golden Path, and Wild Mariposa, in consideration for the issuance of 11,544,400 common shares and 15,055,600 common shares (collectively, the “Consideration Shares“), respectively. The Consideration Shares will be issued to the existing members of Golden Path, and Wild Mariposa, at a deemed price of Cdn$0.195 per share.

The Company is at arms-length from each of Golden Path, Wild Mariposa and their respective members. The transactions contemplated by the Letters of Intent do not constitute a fundamental change for the company, nor are they expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The transactions are contingent upon each other, and the Company does not intend to proceed with the transactions unless both can be completed concurrently. Upon completion of the transactions, an administrative fee of 266,000 common shares of the Company will be owing to a consultant who assisted with the transactions.

The transactions remain subject to a number of conditions, including completion of due diligence, receipt of any required regulatory approval and the negotiation of definitive documentation, which is expected to include warranties, representations, covenants, terms and conditions which are customary and consistent with industry standards for transactions of this nature. The transactions cannot be completed until these conditions have been satisfied.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS

THOUGHTFUL BRANDS INC.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to its plans to acquire Golden Path and Wild Mariposa, along with additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its eCommerce technology platform. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Thoughtful Brands Inc.

#Nickel hits highest in nearly 9 months on Philippine supply concerns SPONSOR Tartisan #Nickel $TN.ca $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 5:48 PM on Monday, August 17th, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including an equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

Nickel hits highest in nearly 9 months on Philippine supply concerns

  • Nickel prices surged to their highest in nearly nine months on Monday on concern over supply from the Philippines, the leading exporter of the stainless steel raw material
  • Copper and most other industrial metals also pushed higher after the central bank of top commodities consumer China injected fresh funds into the financial system

(Updates with official prices) By Eric Onstad LONDON, Aug 17 (Reuters) – Nickel prices surged to their highest in nearly nine months on Monday on concern over supply from the Philippines, the leading exporter of the stainless steel raw material. Copper and most other industrial metals also pushed higher after the central bank of top commodities consumer China injected fresh funds into the financial system. “This remains a liquidity-driven market. Most investors are still expecting the Chinese economy to perform well in the future, so they see good reason to stick to the bullish side of the market,” said Gianclaudio Torlizzi, a partner at Milan consultancy T-Commodity. Three-month nickel on the London Metal Exchange (LME) climbed 1.6% to $14,602 a tonne in official trading after hitting $14,665, its strongest since Nov. 25. Nickel ore output from the Philippines, the world’s biggest exporter of the material, dropped 28% year on year to 102,310 tonnes by metal content over January-June, data showed.
* Also supporting nickel were strong ShFE stainless steel futures , which climbed as much as 4.2% to 14,775 yuan a tonne. Most nickel is used as an alloy to make stainless steel.
* Nickel ore prices at Philippine ports were hovering at their highest in eight and a half months at $10.25 a tonne, data from metals prices provider SMM showed.
* LME copper advanced 1% to $6,428 a tonne, though T-Commodity’s Torlizzi was wary of the strong recent gains that have lifted the price by 47% since March and prompted him to take a short position. “We think the risk of being long here is high and is very vulnerable to disappointment.”
* LME copper stocks sank to their lowest levels in more than 12 years to 110,000 tonnes.

* LME zinc jumped 2.4% in official activity to its highest in nearly seven months at $2,423.50 a tonne as aluminium rose 0.6% to $1,757. Lead gained 1.2% to $1,973.50, its strongest since Jan. 23, but tin shed 1% to $17,426.
* For the top stories in metals and other news, click or . ($1 = 6.9382 yuan) (Additional reporting by Mai Nguyen Editing by Jan Harvey and David Goodman)

Source: https://www.kitco.com/news/2020-08-17/METALS-Nickel-hits-highest-in-nearly-9-months-on-Philippine-supply-concerns.html